A Study of Thyroid Profile and Lipid Profile in Patients with Chronic Kidney Disease with or without Hemodialysis in a Tertiary Care Hospital.

BACKGROUND Chronic kidney disease (CKD), due to increasing frequency and prevalence, has become one of the leading public health issues. The Kidney Disease Outcome Quality Initiative (KDOQI) defines CKD as kidney injury or a reduction in the glomerular filtration rate (GFR) to <60 mL/minute/1.73 m2 for at least 3 months. This study aims to compare the effects of decreased renal function on thyroid profile and lipid profile in CKD patients. MATERIALS AND METHODS This is a prospective cross-sectional observational study conducted among the patients attending Outpatient Department/Inpatient Department (OPD/IPD) at the School of Medical Sciences & Research, Sharda Hospital, Greater Noida, Uttar Pradesh, India, in known cases of CKD, irrespective of the treatment/stage of CKD. All patients of >18 years of age with CKD were included in the study. RESULT A total of 200 patients who met the inclusion criteria were included after obtaining detailed informed consent, of which 100 were cases and 100 were controls. The mean age of patients in the study was 47.74 years, with the mean age in patients with CKD 52 years, and the control was 43 years. The mean level of triglycerides (TGs) was significantly higher among the cases, and the high-density lipoprotein (HDL) was significantly lower among cases compared to controls (p < 0.05). Pearson's correlation between thyroid-stimulating hormone (TSH) with creatinine showed a weak albeit significant positive association (r = 0.200; p < 0.05). CONCLUSION Our study shows a higher incidence of alteration in thyroid profile and dyslipidemia among the patients with CKD compared to controls. There is a necessary need to screen routinely for hypothyroidism and dyslipidemia among patients with CKD. Importantly, thyroid hormone levels and their effects on the progression of CKD have not been studied exhaustively.

[1]  Raman Sharma,et al.  Correlation of Thyroid Hormone Profile with Biochemical Markers of Renal Function in Patients with Undialyzed Chronic Kidney Disease , 2018, Indian journal of endocrinology and metabolism.

[2]  D. N. Adjei,et al.  Thyroid hormone status in Ghanaian patients with chronic kidney disease , 2018, The Pan African medical journal.

[3]  N. Baral,et al.  Thyroid dysfunction and dyslipidemia in chronic kidney disease patients , 2015, BMC Endocrine Disorders.

[4]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  L. F. Gonçalves,et al.  Prevalence of Cardiovascular Risk Factors in Hemodialysis Patients - The CORDIAL Study , 2014, Arquivos brasileiros de cardiologia.

[6]  M. Kuo,et al.  Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease , 2013, PloS one.

[7]  J. A. Parmar,et al.  Dyslipidemia and Chronic Kidney Disease , 2012 .

[8]  A. Mohapatra,et al.  Interactions between thyroid disorders and kidney disease , 2012, Indian journal of endocrinology and metabolism.

[9]  Ashwini A. Balode,et al.  Serum Lipid Profile in Chronic Kidney Disease Patients on Haemodialysis , 2011 .

[10]  Mohamed H. Ahmed,et al.  Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[11]  E. Ritz,et al.  Dyslipidemia in chronic kidney disease: pathogenesis and intervention. , 2009, Polskie Archiwum Medycyny Wewnetrznej.

[12]  C. Wanner,et al.  Reducing lipids for CV protection in CKD patients-current evidence. , 2008, Kidney international. Supplement.

[13]  M. Tonelli,et al.  Statins for Treatment of Dyslipidemia in Chronic Kidney Disease , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[14]  A. Cases,et al.  Dyslipidemia and the progression of renal disease in chronic renal failure patients. , 2005, Kidney international. Supplement.

[15]  M. Sarnak,et al.  Managing dyslipidemia in chronic kidney disease , 2004, Journal of General Internal Medicine.

[16]  A. Katz,et al.  Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. , 1977, The Journal of clinical investigation.

[17]  Sunil Kumar,et al.  Evaluation of thyroid hormone levels in chronic kidney disease patients. , 2015, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[18]  B. Rajagopalan,et al.  Renal function markers and thyroid hormone status in undialyzed chronic kidney disease , 2013 .